Select Medical Holdings Reports 3.8% Increase in Revenue for Q2 2025; Adjusted EBITDA Rises 6.1%
Select Medical Holdings Corporation reported a 3.8% increase in revenue for Q2 2025, with income from continuing operations rising to $101 million, a 1% increase from Q2 2024. Adjusted EBITDA also rose by 6.1% to $54.8 million, with an adjusted EBITDA margin of 8.6%, slightly down from 8.7% in the previous year. No future financial guidance was provided in the report.
Select Medical Holdings Corporation has reported its financial results for the three and six months ended June 30, 2024, and 2025. For the second quarter of 2025, the company recorded an income from continuing operations, net of tax, amounting to $101 million, reflecting a 1% increase compared to $100 million in the same period of 2024. Adjusted EBITDA for the second quarter of 2025 stood at $54.8 million, up from $53.7 million in the corresponding period of the previous year, marking a 2% rise. The adjusted EBITDA margin was noted at 8.6% in 2025, slightly down from 8.7% in 2024. No specific future financial guidance or outlook was mentioned in the report. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Select Medical Holdings Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: PH41868) on July 31, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
